MiniMed Group, Inc. (MMED)

MiniMed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jan 23, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Revenue	2,989	2,715	2,469	2,245
Revenue Growth (YoY)	21.06%	9.96%	9.98%	-
Cost of Revenue	1,383	1,187	1,032	937
Gross Profit	1,605	1,528	1,436	1,308
Selling, General & Admin	1,160	1,080	1,057	960
Research & Development	457	436	437	429
Other Operating Expenses	232	157	11	-12
Total Operating Expenses	1,849	1,673	1,505	1,377
Operating Income	-245	-146	-69	-69
Total Non-Operating Income (Expense)	-1	-1	-1	-7
Pretax Income	-245	-147	-70	-76
Provision for Income Taxes	56	52	38	16
Net Income	-239	-213	-112	-96
Minority Interest in Earnings	21	15	5	5
Net Income to Common	-239	-213	-112	-96
Shares Outstanding (Basic)	253	253	-	-
Shares Outstanding (Diluted)	253	253	-	-
EPS (Basic)	-0.94	-0.84	-	-
EPS (Diluted)	-0.94	-0.84	-	-
Shares Outstanding	252.81	252.81	-	-
Free Cash Flow	-168	-53	-107	-173
Free Cash Flow Per Share	-0.66	-0.21	-	-
Gross Margin	53.70%	56.28%	58.16%	58.26%
Operating Margin	-8.20%	-5.38%	-2.79%	-3.07%
Profit Margin	-10.04%	-7.29%	-4.33%	-4.10%
FCF Margin	-5.62%	-1.95%	-4.33%	-7.71%
EBITDA	-90	-3	60	46
EBITDA Margin	-3.01%	-0.11%	2.43%	2.05%
EBIT	-245	-146	-69	-69
EBIT Margin	-8.20%	-5.38%	-2.79%	-3.07%
Effective Tax Rate	-22.86%	-35.37%	-54.29%	-21.05%

Updated Apr 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q